⌘K

Login Start Free

Home/Filings/4/0001140361-23-050617

4//SEC Filing

Chen Ruoyu 4

Accession 0001140361-23-050617

CIK 0001124105other

View on SEC.gov Company Profile

Filed

Oct 31, 8:00 PM ET

Accepted

Nov 1, 6:15 AM ET

Size

5.0 KB

Accession

0001140361-23-050617

Insider Transaction Report

Form 4

Period: 2023-10-31

GYRE THERAPEUTICS, INC.GYRE

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2023-10-31+34,380→ 34,380 total
Exercise: $6.93Exp: 2033-10-31→ Common Stock (34,380 underlying)

Footnotes (1)

[F1]These options are vested in full.

Documents

1 file

4
form4.xmlPrimary

Issuer

GYRE THERAPEUTICS, INC.

CIK 0001124105

Entity typeother

Related Parties

1

filerCIK 0001982080

Filing Metadata

Form type: 4
Filed: Oct 31, 8:00 PM ET
Accepted: Nov 1, 6:15 AM ET
Size: 5.0 KB

View on SEC.gov